Skip to main content
logo
InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
1.560
-0.030 (-1.89%)
At close: Jun 4, 2026, 4:00 PM EDT
1.470
-0.090 (-5.77%)
After-hours: Jun 4, 2026, 7:35 PM EDT

InMed Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-8.51-8.16-7.68-7.95-18.6-10.2
Depreciation & Amortization
0.580.530.60.60.510.23
Stock-Based Compensation
0.110.120.140.280.780.61
Other Adjustments
0.090.080.320.364.80.12
Change in Receivables
0.18-0.11-0.09-0.22-0.040.04
Changes in Inventories
-0.20.280.070.57-2-
Changes in Accounts Payable
-0.22-0.250.05-0.81-0.810.35
Changes in Other Operating Activities
-0.55-0.26-0.39-0.11-0.22-0.93
Operating Cash Flow
-7.46-7.77-6.99-7.28-15.58-9.79
Capital Expenditures
---0.01-0.16-0.04-0
Purchases of Investments
-0.04-0.04-0.04-0.04--
Proceeds from Sale of Investments
0.040.040.040.04--
Payments for Business Acquisitions
----0.5-0.21-
Other Investing Activities
-----0.43-
Investing Cash Flow
-0-0.01-0.66-0.67-0
Long-Term Debt Repaid
-----0.29-
Net Long-Term Debt Issued (Repaid)
-----0.29-
Issuance of Common Stock
413.165.2210.6817.1512.47
Net Common Stock Issued (Repurchased)
413.165.2210.6817.1512.47
Other Financing Activities
-0.45-0.88-0.56--1.78-1.62
Financing Cash Flow
8.2712.274.6510.6815.0710.85
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-----0.49
Net Cash Flow
0.814.5-2.342.74-1.191.56
Free Cash Flow
-7.46-7.77-7-7.45-15.62-9.79
FCF Margin
-231.35%-157.14%-152.14%-180.02%-1434.03%-
Free Cash Flow Per Share
-2.22-7.96-18.36-60.81-557.13-728.62
Levered Free Cash Flow
-8.91-7.85-7.36-7.86-21.45-10.56
Unlevered Free Cash Flow
-9.18-7.63-7.87-8.33-19.82-10.3
SEC Filings: 10-K · 10-Q